UPL Ltd.
UPL · NSE · Basic Materials
With a 20% margin of safety, our buy-below price is ₹932.56.
Piotroski F-score 6/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%5.6%
- ✕Low debt (D/E < 0.5)0.57x
- ✓Positive free cash flow
- ✓Revenue growth > 10%18%
- ✓Earnings growing33%
- ✕Net margin ≥ 10%3.7%
- ✕Current ratio > 1.51.22
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✕Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✕Altman Z in safe zoneZ 1.53
- ✕Piotroski ≥ 76/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Weaknesses
- •Low return on equity (5.6%).
- •Price below its 200-day moving average (downtrend).
Opportunities
- •Earnings growing (33% YoY).
- •Revenue growing (18% YoY).
- •Trading in our value buy zone versus sector peers.
- •Trades ~89% below our estimated fair value.
Threats
- •Balance-sheet stress — Altman Z 1.53.
About UPL Ltd.
UPL Limited, together with its subsidiaries, manufactures and sells pesticides, insecticides, and micronutrients in India, Brazil, the United States, the United Kingdom, and internationally. It operates in three segments: Crop Protection, Seeds, and Non-Agro. The company offers herbicides, fungicides, insecticides, acaricides, seed treatment, adjuvants, bio-solutions, public health products, fumigants, soil and water technologies, agrochemical products, and other agricultural
More in Chemicals
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.